Apop Biosciences

Apop’s breakthrough CalRexin® technologies are transforming our knowledge of complex cell stress mechanisms associated with programmed cell death (PCD) and autophagy which are important for several significant diseases. We have launched a pipeline of proprietary novel imaging reagents to interrogate these mechanisms, to be followed by a range of emerging therapeutics and diagnostics products. All Apop products are based on our proprietary calcitonin receptor antibody technology, CalRexin®, that targets a novel extracellular marker of these complex processes, is accumulated into live stressed cells and so far is proven for detection of apoptosis and autophagy.